Completed PHASE4 INTERVENTIONAL NCT00119080

Effect of Meningococcal Conjugate Vaccine on Meningococcal Carriage

Evaluation of the Effect of Tetravalent (A, C, Y, W-135) Meningococcal Conjugate Vaccine on Serogroup-Specific Carriage of Neisseria Meningitidis

Sponsor: Centers for Disease Control and Prevention

Conditions Meningitis

Interventions meningococcal conjugate vaccine (Menactra)

Updated 5 times since 2017 Last updated: Mar 16, 2007 Started: Aug 31, 2006 Completion: May 31, 2007

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Meningitis, this trial is completed. The trial is conducted by Centers for Disease Control and Prevention and has accumulated 5 data snapshots since 2006. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Aug 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Centers for Disease Control and Prevention
Georgia Department of Human Resources
Johns Hopkins University
Maryland Department of Health and Mental Hygiene
University of Pittsburgh

Data source: Centers for Disease Control and Prevention

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.